144 related articles for article (PubMed ID: 33274654)
1. A unique case of
Doub JB; Greenfield A; Bailey J; Wessell AP; Olexa J; Sansur CA
Br J Neurosurg; 2023 Oct; 37(5):1281-1284. PubMed ID: 33274654
[TBL] [Abstract][Full Text] [Related]
2. Treatment of rhinocerebral mucormycosis with intravenous interstitial, and cerebrospinal fluid administration of amphotericin B: case report.
Adler DE; Milhorat TH; Miller JI
Neurosurgery; 1998 Mar; 42(3):644-8; discussion 648-9. PubMed ID: 9527000
[TBL] [Abstract][Full Text] [Related]
3. Intracavitary amphotericin B in the treatment of intracranial aspergillosis.
Kural C; Ozer MI; Ezgu MC; Mehtiyev R; Yasar S; Kutlay AM; Daneyemez MK; Onguru O; Erdogan E; Izci Y
J Clin Neurosci; 2018 May; 51():75-79. PubMed ID: 29506772
[TBL] [Abstract][Full Text] [Related]
4. Mucor cerebral abscess associated with intravenous drug abuse.
Fong KM; Seneviratne EM; McCormack JG
Aust N Z J Med; 1990 Feb; 20(1):74-7. PubMed ID: 2322206
[TBL] [Abstract][Full Text] [Related]
5. Continual intracavitary administration of amphotericin B as an adjunct in the treatment of aspergillus brain abscess: case report and review of the literature.
Camarata PJ; Dunn DL; Farney AC; Parker RG; Seljeskog EL
Neurosurgery; 1992 Sep; 31(3):575-9. PubMed ID: 1407438
[TBL] [Abstract][Full Text] [Related]
6. Rhinocerebral mucormycosis. Therapy with amphotericin B lipid complex.
Strasser MD; Kennedy RJ; Adam RD
Arch Intern Med; 1996 Feb; 156(3):337-9. PubMed ID: 8572846
[TBL] [Abstract][Full Text] [Related]
7. Use of external ventriculostomy and intrathecal anti-fungal treatment in cerebral mucormycotic abscess.
Grannan BL; Yanamadala V; Venteicher AS; Walcott BP; Barr JC
J Clin Neurosci; 2014 Oct; 21(10):1819-21. PubMed ID: 24852901
[TBL] [Abstract][Full Text] [Related]
8. [Treatment review in rhinocerebral mucormycosis].
Pardal Refoyo JL; Chocarro Martínez A; Brezmes Valdivieso MF; Parra Pérez C
An Otorrinolaringol Ibero Am; 1998; 25(1):45-56. PubMed ID: 9542247
[TBL] [Abstract][Full Text] [Related]
9. Rhinocerebral mucormycosis treated with amphotericin B colloidal dispersion in three patients.
Moses AE; Rahav G; Barenholz Y; Elidan J; Azaz B; Gillis S; Brickman M; Polacheck I; Shapiro M
Clin Infect Dis; 1998 Jun; 26(6):1430-3. PubMed ID: 9636875
[TBL] [Abstract][Full Text] [Related]
10. Long-term survival in rhinocerebral mucormycosis. Case report.
Weprin BE; Hall WA; Goodman J; Adams GL
J Neurosurg; 1998 Mar; 88(3):570-5. PubMed ID: 9488314
[TBL] [Abstract][Full Text] [Related]
11. Local amphotericin for fungal brain abscess.
Langmayr JJ; Schwarz A; Buchberger W; Hochleitner W; Twerdy K
Lancet; 1993 Jul; 342(8863):123. PubMed ID: 8100896
[No Abstract] [Full Text] [Related]
12. Comparative pharmacodynamics of amphotericin B lipid complex and liposomal amphotericin B in a murine model of pulmonary mucormycosis.
Lewis RE; Albert ND; Liao G; Hou J; Prince RA; Kontoyiannis DP
Antimicrob Agents Chemother; 2010 Mar; 54(3):1298-304. PubMed ID: 20038620
[TBL] [Abstract][Full Text] [Related]
13. Successful treatment of invasive mould infection affecting lung and brain in an adult suffering from acute leukaemia.
Buxhofer V; Ruckser R; Kier P; Habertheuer KH; Tatzreiter G; Zelenka P; Dorner S; Sebesta C; Knosp E; Hruby W; Hinterberger W
Eur J Haematol; 2001 Aug; 67(2):128-32. PubMed ID: 11722602
[TBL] [Abstract][Full Text] [Related]
14. Successful management of cerebral and pulmonary mucormycosis with liposomal amphotericin B in a 28-year-old woman with acute lymphoblastic leukemia.
Salonen JH
Acta Biomed; 2006; 77 Suppl 2():28-31. PubMed ID: 16918065
[TBL] [Abstract][Full Text] [Related]
15. Possible pulmonary Rhizopus oryzae infection in a previously healthy child after a near-drowning incident.
Gerlach MM; Lippmann N; Kobelt L; Petzold-Quinque S; Ritter L; Kiess W; Siekmeyer M
Infection; 2016 Jun; 44(3):361-4. PubMed ID: 26365402
[TBL] [Abstract][Full Text] [Related]
16. Liposomal amphotericin B, and not amphotericin B deoxycholate, improves survival of diabetic mice infected with Rhizopus oryzae.
Ibrahim AS; Avanessian V; Spellberg B; Edwards JE
Antimicrob Agents Chemother; 2003 Oct; 47(10):3343-4. PubMed ID: 14506054
[TBL] [Abstract][Full Text] [Related]
17. Rhinocerebral mucormycosis in the era of lipid-based amphotericin B: case report and literature review.
Mondy KE; Haughey B; Custer PL; Wippold FJ; Ritchie DJ; Mundy LM
Pharmacotherapy; 2002 Apr; 22(4):519-26. PubMed ID: 11939688
[TBL] [Abstract][Full Text] [Related]
18. Liposomal amphotericin B: a review of its use as empirical therapy in febrile neutropenia and in the treatment of invasive fungal infections.
Moen MD; Lyseng-Williamson KA; Scott LJ
Drugs; 2009; 69(3):361-92. PubMed ID: 19275278
[TBL] [Abstract][Full Text] [Related]
19. A mucormycosis case treated with a combination of caspofungin and amphotericin B.
Kazak E; Aslan E; Akalın H; Saraydaroğlu O; Hakyemez B; Erişen L; Yazıcı B; Gürcüoğlu E; Yılmaz E; Ener B; Helvacı S
J Mycol Med; 2013 Sep; 23(3):179-84. PubMed ID: 23856448
[TBL] [Abstract][Full Text] [Related]
20. Isolated cerebral mucormycosis caused by
Farid S; AbuSaleh O; Liesman R; Sohail MR
BMJ Case Rep; 2017 Oct; 2017():. PubMed ID: 28978601
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
